Patent assignee · US · COMPANY

PSIVIDA US, INC.

18Patents
18Active
18Granted
52Portfolio score

Filing activity: Nov 13, 2003 → Nov 7, 2016 · 8 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8192408B2 Ocular trocar assembly Human Necessities 40 Active
US7998108B2 Injector apparatus and method of use Human Necessities 34 Active
US8790293B2 Injector apparatus with fixed plunger and method of use Human Necessities 12 Active
US9023896B2 Porous silicon drug-eluting particles Human Necessities 12 Active
US8871241B2 Injectable sustained release delivery devices Human Necessities 10 Active
US8252307B2 Method for treating and/or preventing retinal diseases with sustained release corticosteroids Human Necessities 9 Active
US8574659B2 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof Emerging Cross-Sectional Technologies 8 Active
US8574613B2 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof Emerging Cross-Sectional Technologies 6 Active
US8815284B2 Bioerodible sustained release drug delivery systems Human Necessities 5 Active
US9603801B2 Bioerodible silicon-based compositions for delivery of therapeutic agents Chemistry; Metallurgy 4 Active
US9486459B2 Porous silicon drug-eluting particles Human Necessities 1 Active
US9192579B2 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof Emerging Cross-Sectional Technologies 1 Active
US9980911B2 Bioerodible silicon-based compositions for delivery of therapeutic agents Chemistry; Metallurgy 1 Active
US9962396B2 Porous silicon drug-eluting particles Human Necessities 0 Active
US9566336B2 In situ gelling drug delivery system Human Necessities 0 Active
US9333173B2 Bioerodible silicon-based devices for delivery of therapeutic agents Chemistry; Metallurgy 0 Active
US9808421B2 Bioerodible silicon-based devices for delivery of therapeutic agents Chemistry; Metallurgy 0 Active
US9849085B2 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.